Interview with Sarah Rutherford, MD from Weill Cornell Medicine at ASH 2023. Filmed December 10, 2023.
ASH ABSTRACT: Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826
[ Ссылка ]
The HealthTree Foundation brings information from the experts to the patients! Learn more at [ Ссылка ]
Donate to the HealthTree Foundation or learn more about additional blood cancer support we offer here: [ Ссылка ]
HealthTree Cure Hub helps you find your best treatment options and accelerate cure for blood cancers. Join today at [ Ссылка ]
